Chapter 2 Summary and Highlights
- Market Outlook
- Market Summary
Chapter 3 Market Overview
- Definitions of Adult Obesity and Overweight
- Overweight- and Obesity-Related Diseases
- Rising Prevalence of Obesity
- Impact of Obesity on Global Economy
- Increasing Awareness Regarding Obesity
- SWOT Analysis
- Strengths
- Weaknesses
- Opportunities
- Threats
Chapter 4 Global Market for Anti-obesity Drugs by Type
- Prescription Drugs
- Over-the-Counter Anti-obesity Drugs
Chapter 5 Global Market for Anti-obesity Drugs by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Chapter 6 Global Market for Anti-obesity Drugs by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 7 ESG Developments
- Introduction to ESG
- Importance of ESG in Anti-obesity Drugs Industry
- ESG Pillars in the Anti-obesity Drug Industry
- Environmental Metrics
- Social Metrics
- Governance Metrics
- ESG Ratings and Metrics: Understanding the Data
- ESG Practices in the Anti-obesity Drug Industry
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks from the Publisher
Chapter 8 Competitive Landscape
- Overview
- Pipeline Analysis
- Patents on Obesity Management, 2020-2023
Chapter 9 Company Profiles
- Altimmune Inc.
- Boehringer Ingelheim International Gmbh
- Currax Pharmaceuticals Llc
- Eli Lilly And Co.
- F. Hoffmann-La Roche Ag
- Glaxosmithkline Plc
- Novo Nordisk A/S
- Pfizer Inc.
- Rhythm Pharmaceuticals, Inc.
- Vivus Llc
List of Tables
Summary Table: Global Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 1: Definitions of Adult Obesity and Overweight
Table 2: Number of People, Aged Over 5 Years, and Percentage of the Population With Overweight or Obesity, 2020-2035
Table 3: Global Obesity Trends for Children and Adolescents, Aged 5 to 19 Years, by Gender, 2020-2035
Table 4: Global Obesity Trends for Adults, Aged 20 Years and Above, by Gender, 2020-2035
Table 5: Global Economic Impact of High BMI (BMI =25kg/m²), 2020-2035
Table 6: Global Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 7: Difference between Prescription Drugs and Over-the-Counter Anti-obesity Drugs
Table 8: Approved Prescription Drugs to Treat Overweight and Obesity
Table 9: Global Market for Anti-obesity Prescription Drugs, by Region, Through 2028
Table 10: Global Market for Over-the-Counter Anti-obesity Drugs, by Region, Through 2028
Table 11: Global Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 12: Global Market for Anti-obesity Drugs Sold through Hospital Pharmacies, by Region, Through 2028
Table 13: Global Market for Anti-obesity Drugs Sold through Retail Pharmacies, by Region, Through 2028
Table 14: Global Market for Anti-obesity Drugs Sold through Online Pharmacies, by Region, Through 2028
Table 15: Global Market for Anti-obesity Drugs, by Region, Through 2028
Table 16: North American Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 17: North American Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 18: European Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 19: European Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 20: Asia-Pacific Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 21: Asia-Pacific Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 22: Rest of the World Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 23: Rest of the World Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 24: ESG Ratings and Metrics
Table 25: Environmental Performance
Table 26: Social Performance
Table 27: Governance Performance
Table 28: ESG Rankings for Major Anti-obesity Drug Companies, 2023*
Table 29: Anti-obesity Drugs in Clinical Trials, 2023
Table 30: Patents on Obesity Management, 2020-2023
Table 31: Altimmune: Pipeline Products
Table 32: Altimmune: News, 2023
Table 33: Boehringer Ingelheim: Pipeline Products
Table 34: Boehringer Ingelheim: News, 2023
Table 35: Currax Pharmaceuticals LLC: Products
Table 36: Currax Pharmaceuticals LLC: News, 2022
Table 37: Eli Lilly: Pipeline Products
Table 38: Eli Lilly: News, 2023
Table 39: ROCHE: Products
Table 40: GlaxoSmithKline: Products
Table 41: Novo Nordisk A/S: Products
Table 42: Novo Nordisk A/S: Pipeline Products
Table 43: Novo Nordisk A/S: News, 2023
Table 44: Pfizer: Pipeline Products
Table 45: Pfizer: News, 2023
Table 46: Rhythm Pharmaceuticals: Products
Table 47: Rhythm Pharmaceuticals: Pipeline Products
Table 48: Rhythm Pharmaceuticals: News, 2023
Table 49: VIVUS LLC: Products
Table 50: VIVUS LLC: News, 2023
List of Figures
Summary Figure: Global Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 1: Global Market for Anti-obesity Drugs: SWOT Analysis
Figure 2: Global Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 3: Global Market for Anti-obesity Prescription Drugs, by Region, 2021-2028
Figure 4: Global Market for Over-the-Counter Anti-obesity Drugs, by Region, 2021-2028
Figure 5: Global Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 6: Global Market for Anti-obesity Drugs Sold through Hospital Pharmacies, by Region, 2021-2028
Figure 7: Global Market for Anti-obesity Drugs Sold through Retail Pharmacies, by Region, 2021-2028
Figure 8: Global Market for Anti-obesity Drugs Sold through Online Pharmacies, by Region, 2021-2028
Figure 9: Global Market Shares of Anti-obesity Drugs, by Region, 2023
Figure 10: North American Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 11: North American Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 12: European Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 13: European Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 14: Asia-Pacific Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 15: Asia-Pacific Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 16: Rest of the World Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 17: Rest of the World Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028